These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2265899)

  • 1. Mood-dependent fluctuations in the severity of tardive dyskinesia and psoriasis vulgaris in a patient with schizoaffective disorder: possible role of melatonin.
    Sandyk R; Pardeshi R
    Int J Neurosci; 1990 Feb; 50(3-4):215-21. PubMed ID: 2265899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tardive dyskinesia in bipolar disorders: possible role of pineal melatonin.
    Sandyk R
    Int J Neurosci; 1990 Jun; 52(3-4):233-8. PubMed ID: 2269610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tardive dyskinesia associated with depression in a bipolar patient: possible role of melatonin.
    Sandyk R
    Int J Neurosci; 1990 May; 52(1-2):79-83. PubMed ID: 1979969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of pineal calcification and melatonin secretion to the pathophysiology of tardive dyskinesia and Tourette's syndrome.
    Sandyk R; Kay SR
    Int J Neurosci; 1991 Jun; 58(3-4):215-47. PubMed ID: 1365044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of pineal calcification to subtypes of tardive dyskinesia in bipolar patients.
    Sandyk R
    Int J Neurosci; 1990 Oct; 54(3-4):307-13. PubMed ID: 2265981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pineal calcification and subtypes of tardive dyskinesia.
    Sandyk R
    Int J Neurosci; 1990 Aug; 53(2-4):223-9. PubMed ID: 1979971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of serotonin metabolism and melatonin secretion to the pathophysiology of tardive dyskinesia.
    Sandyk R; Fisher H
    Int J Neurosci; 1989 Sep; 48(1-2):133-6. PubMed ID: 2583928
    [No Abstract]   [Full Text] [Related]  

  • 8. Heterogeneity of tardive dyskinesia. A multivariate analysis.
    Glazer WM; Morgenstern H; Niedzwiecki D; Hughes J
    Br J Psychiatry; 1988 Feb; 152():253-9. PubMed ID: 3262396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affective disorders and tardive dyskinesia.
    Casey DE
    Encephale; 1988 Sep; 14 Spec No():221-6. PubMed ID: 2905650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin for the treatment of tardive dyskinesia.
    Nelson LA; McGuire JM; Hausafus SN
    Ann Pharmacother; 2003; 37(7-8):1128-31. PubMed ID: 12841828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Mood Disorder.
    Correll CU; Josiassen RC; Liang GS; Burke J; O'Brien CF
    Psychopharmacol Bull; 2017 Aug; 47(3):53-60. PubMed ID: 28839340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The protective function of the pineal gland in tardive dyskinesia.
    Sandyk R; Fisher H
    Int J Neurosci; 1988 Dec; 43(3-4):215-8. PubMed ID: 3243679
    [No Abstract]   [Full Text] [Related]  

  • 13. The effects of valbenazine on tardive dyskinesia in patients with a primary mood disorder.
    McIntyre RS; Calabrese JR; Nierenberg AA; Farahmand K; Yonan C; Siegert S; Burke J
    J Affect Disord; 2019 Mar; 246():217-223. PubMed ID: 30583148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin treatment for tardive dyskinesia: a double-blind, placebo-controlled, crossover study.
    Shamir E; Barak Y; Shalman I; Laudon M; Zisapel N; Tarrasch R; Elizur A; Weizman R
    Arch Gen Psychiatry; 2001 Nov; 58(11):1049-52. PubMed ID: 11695951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal Involuntary Movement Scale (AIMS) and Extrapyramidal Symptom Rating Scale (ESRS): cross-scale comparison in assessing tardive dyskinesia.
    Gharabawi GM; Bossie CA; Lasser RA; Turkoz I; Rodriguez S; Chouinard G
    Schizophr Res; 2005 Sep; 77(2-3):119-28. PubMed ID: 15913963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Valbenazine (NBI-98854) in Treating Subjects with Tardive Dyskinesia and Schizophrenia or Schizoaffective Disorder.
    Kane JM; Correll CU; Liang GS; Burke J; O'Brien CF
    Psychopharmacol Bull; 2017 Aug; 47(3):69-76. PubMed ID: 28839342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
    Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
    Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tardive dyskinesia: current clinical issues.
    Burke RE
    Neurology; 1984 Oct; 34(10):1348-53. PubMed ID: 6148718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocyte-stimulating hormone and persistent tardive dyskinesia: a hypothesis.
    Sandyk R
    Int J Neurosci; 1990 Mar; 51(1-2):45-52. PubMed ID: 1979965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worsening of psychosis in schizophrenia is longitudinally associated with tardive dyskinesia in the European Schizophrenia Outpatient Health Outcomes study.
    Tenback DE; van Harten PN; Slooff CJ; van Os J;
    Compr Psychiatry; 2007; 48(5):436-40. PubMed ID: 17707251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.